Trial Profile
The Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine versus 23-Valent Polysaccharide Vaccine in Adults Aged 50-80 Years.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jul 2015
Price :
$35
*
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine
- Indications Pneumococcal infections; Pneumonia
- Focus Pharmacodynamics
- 27 Mar 2012 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 14 Dec 2009 New trial record.